Ruth DevenynsCEO at Precirix, BelgiumSpeaker
Agenda Sessions
Novel Treatment for the Selective Targeting of Metastatic HER2-Positive Cancer
, 8:35amView Session
Novel Treatment for the Selective Targeting of Metastatic HER2-Positive Cancer